image
Healthcare - Biotechnology - NASDAQ - US
$ 0.7667
8.46 %
$ 278 M
Market Cap
-1.43
P/E
Price Target Average
682.57%
Revenue Forecast Estimate
53.66%
EBIT Estimate
3.17%
Net Income Estimate
35.26%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Lexicon Pharmaceuticals, Inc.
image
Wall Street analysts predict an average 1-year price target for LXRX of $6 , with forecasts ranging from a low of $6 to a high of $6 .
LXRX Lowest Price Target Wall Street Target
6 USD 682.57%
LXRX Average Price Target Wall Street Target
6 USD 682.57%
LXRX Highest Price Target Wall Street Target
6 USD 682.57%
Price
Max Price Target
Min Price Target
Average Price Target
66554433221100Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart LXRX

image
$350.0m$350.0m$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart LXRX

image
$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart LXRX

image
$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029